新天药业
(002873)
| 流通市值：21.94亿 | | | 总市值：22.43亿 |
| 流通股本：2.39亿 | | | 总股本：2.44亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 193,151,214.98 | 857,548,653.35 | 660,845,257.81 | 441,699,428.16 |
| 营业收入 | 193,151,214.98 | 857,548,653.35 | 660,845,257.81 | 441,699,428.16 |
| 二、营业总成本 | 189,977,100.17 | 814,798,989.28 | 609,497,817.29 | 403,640,490.3 |
| 营业成本 | 55,139,478.03 | 227,662,274.68 | 172,467,402.43 | 111,790,056.73 |
| 税金及附加 | 4,801,618.81 | 14,840,276.79 | 12,620,478.55 | 7,647,880.87 |
| 销售费用 | 84,366,283.27 | 371,635,977.54 | 271,298,075.9 | 180,032,401.92 |
| 管理费用 | 31,940,888.14 | 142,004,769.83 | 103,896,801.32 | 70,356,310.17 |
| 研发费用 | 9,153,093.49 | 40,473,913.75 | 29,913,962.65 | 21,403,196.45 |
| 财务费用 | 4,575,738.43 | 18,181,776.69 | 19,301,096.44 | 12,410,644.16 |
| 其中:利息费用 | 4,552,028.01 | 17,570,753.56 | 19,610,582.26 | 12,771,532.05 |
| 其中:利息收入 | 110,538.93 | 674,484.2 | 532,659.04 | 405,930.58 |
| 加:公允价值变动收益 | -12,679.5 | 24,344.64 | 10,143.6 | 4,057.44 |
| 资产处置收益 | 67,254.72 | 18,900,390.64 | 18,900,390.64 | 32,466.11 |
| 资产减值损失(新) | -50,373 | -3,193,822.42 | -10,033.31 | 14,800.77 |
| 信用减值损失(新) | -774,194.23 | -1,373,517.1 | -4,066,423.71 | -2,729,170.9 |
| 其他收益 | 2,393,407.28 | 6,090,845.93 | 3,832,613.72 | 2,295,037.71 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 4,797,530.08 | 63,197,905.76 | 70,014,131.46 | 37,676,128.99 |
| 加:营业外收入 | 5,784.11 | 112,957.39 | 108,548.39 | 103,564.26 |
| 减:营业外支出 | 332,031.94 | 2,554,973.82 | 1,855,133.06 | 1,714,246.02 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 4,471,282.25 | 60,755,889.33 | 68,267,546.79 | 36,065,447.23 |
| 减:所得税费用 | 283,827.8 | 8,433,012.19 | 7,267,785.56 | 5,725,996.74 |
| 六、净利润 | 4,187,454.45 | 52,322,877.14 | 60,999,761.23 | 30,339,450.49 |
| 持续经营净利润 | 4,187,454.45 | 52,322,877.14 | 60,999,761.23 | 30,339,450.49 |
| 归属于母公司股东的净利润 | 4,187,454.45 | 52,322,877.14 | 60,999,761.23 | 30,339,450.49 |
| (一)基本每股收益 | 0.02 | 0.24 | 0.26 | 0.13 |
| (二)稀释每股收益 | 0.02 | 0.24 | 0.26 | 0.13 |
| 八、其他综合收益 | - | 24,475,884.26 | - | - |
| 归属于母公司股东的其他综合收益 | - | 24,475,884.26 | - | - |
| 九、综合收益总额 | 4,187,454.45 | 76,798,761.4 | 60,999,761.23 | 30,339,450.49 |
| 归属于母公司股东的综合收益总额 | 4,187,454.45 | 76,798,761.4 | 60,999,761.23 | 30,339,450.49 |
| 公告日期 | 2025-04-25 | 2025-04-25 | 2024-10-28 | 2024-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |